Celldex Therapeutics, Inc. Public Float
Celldex Therapeutics, Inc. (CLDX) had Public Float of $1.30 billion as of 2025-06-30, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-25
- 2025-06-30: Entity Public Float $1.30B.
- 2024-06-30: Entity Public Float $2.40B.
- 2023-06-30: Entity Public Float $1.60B.
- 2022-06-30: Entity Public Float $1.30B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.30B 10-K · filed 2026-02-25 |
| 2024-06-30 | $2.40B 10-K · filed 2025-02-27 |
| 2023-06-30 | $1.60B 10-K · filed 2024-02-26 |
| 2022-06-30 | $1.30B 10-K · filed 2023-02-28 |
| 2021-06-30 | $1.30B 10-K · filed 2022-02-28 |
| 2020-06-30 | $507.00M 10-K · filed 2021-03-29 |
| 2019-06-30 | $40.00M 10-K · filed 2020-03-26 |
| 2018-06-30 | $79.00M 10-K · filed 2019-03-07 |
| 2017-06-30 | $313.00M 10-K · filed 2018-03-07 |
| 2016-06-30 | $435.00M 10-K · filed 2017-03-14 |
| 2015-06-30 | $2.50B 10-K/A · filed 2016-02-25 |
| 2014-06-30 | $1.50B 10-K · filed 2015-02-24 |
| 2013-06-30 | $1.30B 10-K · filed 2014-03-03 |
| 2012-06-30 | $303.20M 10-K · filed 2013-03-08 |
| 2011-06-30 | $156.10M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |